Literature DB >> 12779326

New substrates for beta-lactam-recognizing enzymes: aryl malonamates.

D Cabaret1, S A Adediran, R F Pratt, M Wakselman.   

Abstract

Aryl malonamates are demonstrated to be novel substrates of a broad range of beta-lactam-recognizing enzymes. These compounds are isomers of the aryl phenaceturates, which are well-known substrates of these enzymes, but the new compounds contain a retro-amide side chain. Several lines of evidence, including comparisons of steady-state kinetic parameters between enzymes and a detailed investigation of the methanolysis kinetics, solvent deuterium isotope effects, and pH-rate profile for turnover of a retro substrate by the Enterobacter cloacae P99 beta-lactamase, suggested that the new substrates are likely to be hydrolyzed by the same chemical mechanisms as "normal" substrates. Molecular modeling indicated that the retro-amide group fits snugly into the active site of the P99 beta-lactamase by hydrogen bonding to the conserved lysine-67 residue. The retro-amide side chain may represent a lead to novel mechanism-based and transition state analogue inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12779326     DOI: 10.1021/bi0300478

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Serendipitous discovery of α-hydroxyalkyl esters as β-lactamase substrates.

Authors:  Ryan B Pelto; R F Pratt
Journal:  Biochemistry       Date:  2010-11-18       Impact factor: 3.162

2.  Substituted aryl malonamates as new serine beta-lactamase substrates: structure-activity studies.

Authors:  S A Adediran; D Cabaret; J-F Lohier; M Wakselman; R F Pratt
Journal:  Bioorg Med Chem       Date:  2009-10-31       Impact factor: 3.641

3.  Design, Synthesis and Evaluation of N-pyrazinylbenzamides as Potential Antimycobacterial Agents.

Authors:  Jan Zitko; Alžběta Mindlová; Ondřej Valášek; Ondřej Jand'ourek; Pavla Paterová; Jiří Janoušek; Klára Konečná; Martin Doležal
Journal:  Molecules       Date:  2018-09-18       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.